Medicare on Thursday gave more details on how it plans to cover new Alzheimer’s drugs once they receive full U.S. approval, emphasizing that a required patient registry will be free and easy to use.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,